CLCN3 also accelerates the G0/G1 to S phase transition in the cell cycle by enhancing the phosphorylation of ERK1/2 and upregulating cyclin E and cyclin D1 in multiple myeloma cells (Du et al., 2018). Here, MAPK3 is linked to plasma cell myeloma.